Results

Total Results: 801 records

Showing results for "described".

1. Procedure Manual Appendix I. Congressional Mandate Establishing the U.S. Preventive Services Task Force | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-i
   April 01, 2019 - —The Secretary shall establish a minimum interval between the date on which a recommendation described … guideline under subsection (a)(3) is issued and the plan year with respect to which the requirement described … in subsection (a) is effective with respect to the service described in such recommendation or guideline … —The interval described in paragraph (1) shall not be less than 1 year. SEC. 4105. … section; and ''(2) provide that no payment shall be made under this title for a preventive service described

2. Draft Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/chronic-kidney-disease-screening
   January 19, 2023 - cotransporter-2 inhibitors Glucagon-like peptide-1 agonist Statins Screening tests and treatments not described … intensive vs. less intensive treatment (management of blood pressure or dyslipidemia) Comparisons not described … Sensitivity Specificity Area under the receiver operating characteristic curve Outcomes not described … Controlled observational studies KQs 3, 3a: Studies reporting diagnostic accuracy Study designs not described

3. Final Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-kidney-disease-screening
   July 13, 2023 - cotransporter-2 inhibitors Glucagon-like peptide-1 agonist Statins Screening tests and treatments not described … intensive vs. less intensive treatment (management of blood pressure or dyslipidemia) Comparisons not described … Sensitivity Specificity Area under the receiver operating characteristic curve Outcomes not described … Controlled observational studies KQs 3, 3a: Studies reporting diagnostic accuracy Study designs not described

4. Standards for Guideline Development | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/standards-guideline-development
   June 01, 2018 - Academy of Medicine's (formerly the Institute of Medicine) recommendations for guideline development, as described

5. Screening Children for Family Violence: A Review of the Evidence (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/qCaKmh7ayuG9VP2vj646pQ
   March 01, 2004 - Included studies described the study sample, the screening instrument or procedure, the abuse or neglect … A limited number of studies described the performance of screening methods, such as self-administered … Instruments and scoring procedures included in these studies are described in Appendix 4.49,51–53 Few … Interventions are dissimilar between studies and often inadequately described. … fair quality are described in the text.

6. Archived: Evidence Summary: Child Maltreatment: Counseling, 2004 | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/child-maltreatment-counseling-2004
   March 09, 2004 - Included studies described the study sample, the screening instrument or procedure, the abuse or neglect … A limited number of studies described the performance of screening methods, such as self-administered … Instruments and scoring procedures included in these studies are described in Appendix 4 . 49 , 51-53 … Interventions are dissimilar between studies and often inadequately described. … or fair quality are described in the text.

7. Evidence Gaps Research Taxonomy Table: Primary Care Behavioral Counseling Interventions to Support Breastfeeding (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/5newnV_sfH4xnGCbpoh4Ma
   Interventions: Support interventions described above that are tailored to meet the needs of populations … Breastfeeding measures should be described by duration, intensity, exclusivity, and mode of breast

8. Procedure Manual Appendix VIII. Standardization of Outcome Tables | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-viii-standardization-outcome-tables
   July 01, 2017 - Interventions: Interventions should be shown in columns and described.

9. Procedure Manual Appendix XII. Summary of Evidence Table for Evidence Reviews | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-xii-summary-evidence-table-evidence-reviews
   July 01, 2017 - The number of studies (k) and number of participants (n) for each study design should be described within … in the body of evidence from what is desired to answer the overall key question are qualitatively described

10. Current Processes: Refining Evidence-based Recommendation Development - Table 2 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/current-processes-refining-evidence-based-recommendation-development-table-2
    June 01, 2007 - to Ensure Integrity a Goal Process Transparency Standardized methodology described

11. Archived: Final Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/osteoporosis-screening-june-2018
    November 05, 2015 - structural engineering models, and finite element analysis KQs 4, 5: Interventions other than those described … morbidity and mortality Bone density measures (t-score, z-score) KQs 2–4: Outcomes other than those described

12. Identifying Evidence Gaps | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/identifying-evidence-gaps
    June 01, 2018 - This is described in each recommendation statement in a section called “Research Needs and Gaps.”

13. Archived: Final Evidence Summary: Lung Cancer: Screening, May 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary35/lung-cancer-screening-2004
    May 15, 2004 - For completeness, all studies are described in the tables; however, only studies rated of fair or better … quality are described in the text. … The rate of complications associated with biopsy was not described in the CT studies. … (Confidence interval has been described as the range of two values within which it is probable that the … Relative risk has been described as the ratio of the risk of an event among an exposed population to

14. Procedure Manual Section 2. Topic Selection, Prioritization, and Updating | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-2-topic-selection-prioritization-and-updating
    June 22, 2025 - All potential new topics enter the yearly prioritization process (described in Section 2.3 ). 2.3 … for the topic Referred topics may be reactivated through the usual new topic nomination process (described … This LitWatch process is described in Appendix III .

15. How-To-Read-Recommendations-Fact-Sheet 0 (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/how-to-read-recommendations-fact-sheet_0.pdf
    July 22, 2020 - More detailed information about the methods and processes used by the USPSTF is described in a JAMA

16. Health Equity Framework for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/health-equity-framework-report.pdf
    January 01, 2023 - Many of the processes and methods described below are already part of the USPSTF and EPC procedures … Information on newly identified primary studies published since the last review are described with … If mechanisms for observed disparities are not obvious or well described, this may be important to … The CQs are not routinely described in the Methods section. … In addition, the credibility assessment of subgroup analyses should be described in the Methods.

17. Behavioral Counseling Interventions: An Evidence-based Approach - Figure 1 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/behavioral-counseling-interventions-evidence-based-approach-figure-1
    November 01, 2013 - Sustained Health Behavior Change's is linked directly through another arrow parallel to the first arrow described

18. Procedure Manual | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual
    December 01, 2015 - description of methods used to conduct a systematic evidence review may want to review the methods described

19. ahrq37a_LungCancer_Sum.qxd (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/VN82XmdDhcK74WtHxWBTqm
    May 01, 2004 - For completeness, all studies are described in the tables; however, only studies rated of fair or better … quality are described in the text. … and pathologists blind to study group Johns Hopkins38,68–72 Computer generated randomization (not described … Adequate description; greater number dropouts in control group Blinding not described; nonsystematic … The rate of complications associated with biopsy was not described in the CT studies.

20. Final Research Plan: Asymptomatic Carotid Artery Stenosis: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/carotid-artery-stenosis-screening
    November 14, 2019 - The update for this topic will be conducted using rapid synthesis procedures, as described in Section